Because increased expression of p16, encoded by CDKN2A, is often used as a surrogate marker of HPV-positive HNSCC, we evaluate the correlation between CDKN2A and EGFR expression. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.